TrineBjørgHammer

[Katrine M Johannesen @Katrine92658231]

Our recent paper on KCNQ2 is out now, highlighting the difficulties in variant assessment
#epilepsy #epilepsygenetics #kcnq2 #DEE

[Rikke S. Møller @FiladelfiaGene1]

#DICE2020 We are entering an era of novel disease-modifying therapies targeting the cause of seizures, rather than seizures themselves.

Promising therapies for genetic epilepsies are in the horizon including ASOs, small molecules and repurposed drugs. #PrecisionMedicine

[Rikke S. Møller @FiladelfiaGene1]

24 hours to kickoff of our virtual conference on Precision Medicine in Genetic Epilepsies. I have already watched several of the presentations - its going to be awesome!!! Registration is still open - come and join us😃https://t.co/uIs4eFqY7m

[Rikke S. Møller @FiladelfiaGene1]

The 4th Dianalund International Conference on Epilepsy is going virtual! November 12-13, 2020.

Want to learn more about precision medicine in genetic epilepsies? Register at: https://t.co/3TkqwMWHBS

Abstract deadline October 16!

Read more at: https://t.co/uIs4eFqY7m

[Rikke S. Møller @FiladelfiaGene1]

Excited to share our new manuscript on NEXMIF-encephalopathy: an X-linked, generalized DE/DEE characteriszed by MAE overlapping with EMA @GIMJournal. Fabulous collaboration with Hannah Stamberger, @TrinebjR, @Elegardella, @ingridscheffer & many others.

https://t.co/5PGejUbxCb